Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

SB 292Session 2025-2026

Prohibiting the transfer of hemp-derived cannabinoid products to any person under the age of 21, establishing packaging and labeling requirements for such products and amending the definition of industrial hemp and hemp products.

As Introduced

Underlined text would be added to current law. Struck-through text would be removed.

Skip to main content Kansas Legislature kslegislature.gov menu Home House account_balanceAbout the House groupsRepresentatives campaignEvents chairSeating Chart auto_storiesJournals & Calendars manage_accountsChief Clerk of the House gavelRules Senate account_balanceAbout the Senate groupsSenators campaignEvents assignment_indAppointments chairSeating Chart auto_storiesJournals & Calendars manage_accountsSecretary of the Senate gavelRules Committees groupsCommittees eventHearing Schedule handshakeConference Committee Schedule Measures & Laws gavelAll Measures account_balanceHouse Measures account_balanceSenate Measures account_balanceVotes topicSubject Index summarizeReports menu_bookStatutes schoolHow a Bill Becomes Law menu_bookLegislative Procedure Manual Today campaignLive Floor Activity videocamHouse Video videocamSenate Video live_tvStatehouse Live & Archive smart_displayYouTube Channel Resources Archive Search description Go to bill or resolution arrow_forward A− A+ search Search bills, resolutions, and statutes help

Keywords
Enter any words to search bills, statutes, and documents.
water quality funding

Bill or Resolution Number
Type a number and press Enter to go directly to the detail page.
HB 2590 SCR 1611

Statute Number
68-102 72-3715

Exact Phrase
Wrap your query in quotes.
“rules of evidence”

Document Type
Prefix with a type to narrow results.
testimony: HB 2513 minutes: budget

    Searching…

    No results found.

    search Search bills, resolutions, and statutes Home House About the House Representatives Events Seating Chart Journals & Calendars Chief Clerk of the House Rules Senate About the Senate Senators Events Appointments Seating Chart Journals & Calendars Secretary of the Senate Rules Committees All Committees Hearing Schedule Conference Committee Schedule Measures & Laws All Measures House Measures Senate Measures Votes Subject Index Reports Statutes How a Bill Becomes Law Legislative Procedure Manual Resources Today Live Floor Activity House Video Senate Video Statehouse Live & Archive YouTube Channel Archive Search
    1. SB 292›
    2. SB 292 — As Introduced

    Kansas Legislature

    SB 292 — As Introduced

    picture_as_pdf Download PDF Session of 2025SENATE BILL No. 292By Committee on Federal and State Affairs3-61AN ACT concerning industrial hemp; relating to hemp-derived 2cannabinoid products; prohibiting the transfer of such products to any 3person under the age of 21; establishing packaging and labeling 4requirements for such products; amending the definition of industrial 5hemp and hemp products; amending K.S.A. 2-3908 and K.S.A. 2024 6Supp. 2-3901, 21-5701 and 65-4101 and repealing the existing sections.78Be it enacted by the Legislature of the State of Kansas:9New Section 1. (a) As used in this section:10(1) "Approved source" means:11(A) A person authorized to produce industrial hemp under a state or 12federal plan in accordance with 7 U.S.C. § 1621 et seq., and amendments 13thereto;14(B) a person registered as an industrial hemp processor by the state 15fire marshal; or16(C) a person authorized by another state to process industrial hemp or 17manufacture hemp products if such state has been approved by the Kansas 18department of agriculture as having equivalent state standards for 19processing, laboratory testing and labeling requirements;20(2) "cartoon" means any drawing or other depiction of an object, 21person, animal, creature or any similar caricature that satisfies any of the 22following criteria:23(A) The use of comically exaggerated features;24(B) the attribution of human characteristics to animals, plants or other 25objects, or the similar use of anthropomorphic technique; or26(C) the attribution of unnatural or extra-human abilities, such as 27imperviousness to pain or injury, X-ray vision, tunneling at very high 28speeds or transformation;29(3) "child-resistant" means packaging that is:30(A) Designed or constructed to be significantly difficult for children 31under five years of age to open yet not difficult for adults to use properly; 32and33(B) resealable for any product intended for more than a single use or 34containing multiple servings;35(4) "cosmetic" means the same as defined in K.S.A. 65-656, and 36amendments thereto;1(5) "department" means the Kansas department of agriculture;2(6) "hemp-derived cannabinoid product" means an ingestible, 3inhalable or cosmetic product that is processed or derived from industrial 4hemp; and5(7) "industrial hemp" means the same as defined in K.S.A. 2-3901, 6and amendments thereto.7(b) All hemp-derived cannabinoid products sold in a retail 8establishment shall:9(1) Be from an approved source;10(2) be packaged and labeled in accordance with this section; and11(3) have a valid printed certificate of analysis available upon request.12(c) A hemp-derived cannabinoid product, excluding cosmetics, shall 13not be sold, gifted or otherwise transferred to any person under the age of 1421.15(d) (1) Each hemp-derived cannabinoid product sold or otherwise 16distributed in the state shall bear labeling to allow the consumer to access 17information on the product, including a certificate of analysis for the 18product, the location where the hemp was grown and the address and 19phone number of the manufacturer or distributor. Such labeling shall 20utilize the following:21(A) A scanning bar code, including the batch number or serial 22number of the product;23(B) a quick-response code; or24(C) a web address linked to a document or website.25(2) No product labeling or advertising material for any hemp-derived 26cannabinoid product sold or otherwise distributed in the state shall bear 27any claims stating that the product can diagnose, treat, cure or prevent any 28disease.29(3) Each container or package of hemp-derived cannabinoid product, 30excluding cosmetics, shall:31(A) Have a tamper-evident seal; and32(B) be in child-resistant packaging.33(4) Each container or package of hemp-derived cannabinoid product 34that is a cosmetic shall have a tamper-evident seal.35(5) Hemp-derived cannabinoid product packaging shall not include:36(A) Any cartoon images;37(B) likeness to images, characters or phrases that are popularly used 38to advertise to children;39(C) likeness to or imitation of any commercially available candy, 40snack, baked good or beverage packaging or labeling;41(D) the terms "candy" or "candies", or any variation in the spelling of 42these words; or43(E) the logo of the department, or any seal, flag, crest, coat of arms or 1other insignia that could reasonably mislead any person to believe the 2product has been endorsed, manufactured or used by any state, county, or 3municipality or any agency thereof, excluding the use of seals associated 4with state or federal programs used in accordance with state or federal law.5Sec. 2. K.S.A. 2024 Supp. 2-3901 is hereby amended to read as 6follows: 2-3901. (a) K.S.A. 2-3901 et seq., and amendments thereto, shall 7be known and may be cited as the commercial industrial hemp act.8(b) As used in the commercial industrial hemp act:9(1) "Commercial" means the cultivation or production of industrial 10hemp for any purpose authorized under K.S.A 2-3906, and amendments 11thereto.12(2) "Delta-9 tetrahydrocannabinol concentration" means the 13combined percentage of delta-9 tetrahydrocannabinol and its optical 14isomers, their salts and acids, and salts of their acids, reported as free 15THC:16(A) On a dry weight basis, of any part of the plant cannabis sativa L.; 17or18(B) on a percentage by weight basis in hemp products, waste or 19substances resulting from the production or processing of industrial hemp.20(3) "Effective disposal" includes, but is not limited to:21(A) Destruction; or22(B) any other method of disposing of industrial hemp or hemp 23products found to be in violation of this act that is permitted under the 24provisions of 7 U.S.C. § 1621 et seq. and any rules and regulations 25adopted thereunder.26(4) "Hemp products" means all products made from industrial hemp, 27including, but not limited to, cloth, cordage, fiber, food, fuel, hemp-28derived cannabinoid products, paint, paper, particleboard, plastics, seed, 29seed meal and seed oil for consumption and any extract from industrial 30hemp intended for further processing. Final "hemp products" may contain 31a delta-9 tetrahydrocannabinol concentration of not more than 0.3% on a 32dry weight basis. As used in this paragraph, "tetrahydrocannabinol 33concentration" means the same as in K.S.A. 65-6235(b)(3), and 34amendments thereto.35(5) "Hemp producer" means any individual, licensed or otherwise, 36engaging in the cultivation or production of industrial hemp for 37commercial purposes pursuant to K.S.A. 2-3906, and amendments thereto.38(6) "Hemp processor" means a person registered under K.S.A. 2-393907, and amendments thereto, to process and manufacture industrial 40hemp and hemp products.41(7) "Industrial hemp" or "hemp" means all parts and varieties of the 42plant cannabis sativa L., and any part of that plant, including the seeds 43thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, 1and salts of isomers, whether growing or not, that contain with a delta-9 2tetrahydrocannabinol concentration of not more than 0.3% on a dry weight 3basis.4(8) "Person" means an individual, corporation, partnership, 5association, joint stock company, trust, unincorporated organization or any 6similar entity or any combination of the foregoing acting in concert.7(9) "State educational institution" means the university of Kansas, 8Kansas state university, Wichita state university, Emporia state university, 9Pittsburg state university, Fort Hays state university, or any other 10accredited college, university, technical college or community college 11within Kansas.12(10) "Authorized seed or clone plants" means a source of industrial 13hemp seeds or clone plants that:14(A) Has been certified by a certifying agency, as defined by K.S.A. 2-151415, and amendments thereto;16(B) has been produced from plants that were tested during the active 17growing season and were found to produce industrial hemp having a 18tetrahydrocannabinol concentration that does not exceed 0.3% on a dry 19weight basis and has been certified in writing by the grower or distributor 20of such seeds or clone plants to possess such qualities; or21(C) meets any other authorized standards approved by the Kansas 22department of agriculture through rules and regulations, except that no 23seed or clone plants shall be considered authorized seed or clone plants if 24they do not meet any standard adopted by the United States department of 25agriculture pursuant to 7 U.S.C. § 1621 et seq., and amendments thereto.26(11) "Hemp employee" means a person who has applied for 27employment or is currently employed with the Kansas department of 28agriculture who oversees or regulates industrial hemp.29(12) "Applicant" means a person who has submitted an application 30for licensure as a hemp producer or registration as a hemp processor.31(13) "Hemp destruction employee" means an employee or agent of 32the Kansas department of agriculture who participates in the effective 33disposal of industrial hemp.34Sec. 3. K.S.A. 2-3908 is hereby amended to read as follows: 2-3908. 35(a) (1) It shall be unlawful for any of the following hemp products product 36to be manufactured, marketed, sold or distributed by any person in the 37state of Kansas:38(A) Cigarettes containing industrial hemp;39(B) cigars containing industrial hemp;40(C) chew, dip or other smokeless material containing industrial hemp;41(D) teas containing industrial hemp;42(E) liquids, solids or gases containing industrial hemp for use in 43vaporizing devices; and1(F) any other hemp product that is intended for human or animal 2consumption containing any ingredient derived from industrial hemp that 3is prohibited pursuant to the Kansas food, drug and cosmetic act, K.S.A. 465-636 et seq., and amendments thereto, and the commercial feeding stuffs 5act, K.S.A. 2-1001 et seq., and amendments thereto. This subparagraph 6shall not otherwise prohibit the use of any such ingredient, including 7cannabidiol oil, in such hemp products.8(2) A dietary supplement, food, beverage or cosmetic product is not 9adulterated by the inclusion of industrial hemp as long as the industrial 10hemp in such product meets the requirements in K.S.A. 2-3901 et seq., and 11amendments thereto. The sale of a dietary supplement, food, beverage or 12cosmetic that includes industrial hemp shall not be restricted or prohibited 13based solely on the inclusion of industrial hemp, provided that the 14industrial hemp in the product meets the requirements in K.S.A. 2-3901 et 15seq., and amendments thereto.16(2)(3) As used in this subsection:17(A) "Human or animal consumption" means:18(i) Ingested orally; or19(ii) applied by any means such that an ingredient derived from 20industrial hemp enters the human or animal body.21(B) "Intended for human or animal consumption" means:22(i) Designed by the manufacturer for human or animal consumption;23(ii) marketed for human or animal consumption; or24(iii) distributed with the intent that it be used for human or animal 25consumption.26(b) (1) It shall be unlawful for any of the following hemp products to 27be marketed, sold or distributed to any person in Kansas who is not 28registered as a hemp processor pursuant to K.S.A. 2-3907, and 29amendments thereto, or who does not possess a license by the Kansas 30department of agriculture under any commercial plan established pursuant 31to K.S.A. 2-3906, and amendments thereto, or the research program 32established pursuant to K.S.A. 2-3902, and amendments thereto:33(A) Industrial hemp buds;34(B) ground industrial hemp floral material;35(C) ground industrial hemp leaf material; or36(D) any extract from industrial hemp with a delta-9 37tetrahydrocannabinol concentration greater than 0.3% that will be further 38processed.39(2) No license or registration shall be required for the transport of 40hemp products described in paragraph (1) if such products are transported 41between hemp producers and hemp processors or between more than one 42hemp processor. Any such transportation of hemp products shall be subject 43to rules and regulations promulgated by the state fire marshal pursuant to 1this act.2(c) (1) Upon a first conviction for a violation of this section, a person 3shall be guilty of a class A nonperson misdemeanor.4(2) On a second or subsequent conviction for a violation of this 5section, a person shall be guilty of a severity level 9, nonperson felony.6(d) Nothing in this section shall prohibit:7(1) The use of any hemp product for research purposes by a state 8educational institution or affiliated entity; or9(2) the production, use or sale of any hemp product that is otherwise 10not prohibited by state or federal law.11(e) This section shall be a part of and supplemental to the commercial 12industrial hemp act, K.S.A. 2-3901 et seq., and amendments thereto.13Sec. 4. K.S.A. 2024 Supp. 21-5701 is hereby amended to read as 14follows: 21-5701. As used in K.S.A. 21-5701 through 21-5717, and 15amendments thereto:16(a) "Controlled substance" means any drug, substance or immediate 17precursor included in any of the schedules designated in K.S.A. 65-4105, 1865-4107, 65-4109, 65-4111 and 65-4113, and amendments thereto.19(b) (1) "Controlled substance analog" means a substance that is 20intended for human consumption, and at least one of the following:21(A) The chemical structure of the substance is substantially similar to 22the chemical structure of a controlled substance listed in or added to the 23schedules designated in K.S.A. 65-4105 or 65-4107, and amendments 24thereto;25(B) the substance has a stimulant, depressant or hallucinogenic effect 26on the central nervous system substantially similar to the stimulant, 27depressant or hallucinogenic effect on the central nervous system of a 28controlled substance included in the schedules designated in K.S.A. 65-294105 or 65-4107, and amendments thereto; or30(C) with respect to a particular individual, such individual represents 31or intends the substance to have a stimulant, depressant or hallucinogenic 32effect on the central nervous system substantially similar to the stimulant, 33depressant or hallucinogenic effect on the central nervous system of a 34controlled substance included in the schedules designated in K.S.A. 65-354105 or 65-4107, and amendments thereto.36(2) "Controlled substance analog" does not include:37(A) A controlled substance;38(B) a substance for which there is an approved new drug application; 39or40(C) a substance with respect to which an exemption is in effect for 41investigational use by a particular person under section 505 of the federal 42food, drug, and cosmetic act, 21 U.S.C. § 355, to the extent conduct with 43respect to the substance is permitted by the exemption.1(c) "Cultivate" means the planting or promotion of growth of five or 2more plants that contain or can produce controlled substances.3(d) "Distribute" means the actual, constructive or attempted transfer 4from one person to another of some item whether or not there is an agency 5relationship. "Distribute" includes, but is not limited to, sale, offer for sale 6or any act that causes some item to be transferred from one person to 7another. "Distribute" does not include acts of administering, dispensing or 8prescribing a controlled substance as authorized by the pharmacy act of the 9state of Kansas, the uniform controlled substances act or otherwise 10authorized by law.11(e) (1) "Drug" means:12(A) Substances recognized as drugs in the official United States 13pharmacopeia, official homeopathic pharmacopoeia of the United States or 14official national formulary or any supplement to any of them;15(B) substances intended for use in the diagnosis, cure, mitigation, 16treatment or prevention of disease in humans or animals;17(C) substances, other than food, intended to affect the structure or any 18function of the body of humans or animals; and19(D) substances intended for use as a component of any article 20specified in subparagraph (A), (B) or (C).21(2) "Drug" does not include devices or their components, parts or 22accessories.23(f) (1) "Drug paraphernalia" means all equipment and materials of 24any kind that are used, or primarily intended or designed for use in 25planting, propagating, cultivating, growing, harvesting, manufacturing, 26compounding, converting, producing, processing, preparing, testing, 27analyzing, packaging, repackaging, storing, containing, concealing, 28injecting, ingesting, inhaling or otherwise introducing into the human body 29a controlled substance and in violation of this act.30(2) "Drug paraphernalia" includes, but is not limited to:31(A) Kits used or intended for use in planting, propagating, cultivating, 32growing or harvesting any species of plant that is a controlled substance or 33from which a controlled substance can be derived;34(B) kits used or intended for use in manufacturing, compounding, 35converting, producing, processing or preparing controlled substances;36(C) isomerization devices used or intended for use in increasing the 37potency of any species of plant that is a controlled substance;38(D) testing equipment used or intended for use in identifying or in 39analyzing the strength, effectiveness or purity of controlled substances;40(E) scales and balances used or intended for use in weighing or 41measuring controlled substances;42(F) diluents and adulterants, including, but not limited to, quinine 43hydrochloride, mannitol, mannite, dextrose and lactose that are used or 1intended for use in cutting controlled substances;2(G) separation gins and sifters used or intended for use in removing 3twigs and seeds from or otherwise cleaning or refining marijuana;4(H) blenders, bowls, containers, spoons and mixing devices used or 5intended for use in compounding controlled substances;6(I) capsules, balloons, envelopes, bags and other containers used or 7intended for use in packaging small quantities of controlled substances;8(J) containers and other objects used or intended for use in storing or 9concealing controlled substances;10(K) hypodermic syringes, needles and other objects used or intended 11for use in parenterally injecting controlled substances into the human 12body;13(L) objects used or primarily intended or designed for use in 14ingesting, inhaling or otherwise introducing marijuana, cocaine, hashish, 15hashish oil, phencyclidine (PCP), methamphetamine or amphetamine into 16the human body, such as:17(i) Metal, wooden, acrylic, glass, stone, plastic or ceramic pipes with 18or without screens, permanent screens, hashish heads or punctured metal 19bowls;20(ii) water pipes, bongs or smoking pipes designed to draw smoke 21through water or another cooling device;22(iii) carburetion pipes, glass or other heat-resistant tubes or any other 23device used, intended to be used or designed to be used to cause 24vaporization of a controlled substance for inhalation;25(iv) smoking and carburetion masks;26(v) roach clips, objects used to hold burning material, such as a 27marijuana cigarette, that has become too small or too short to be held in 28the hand;29(vi) miniature cocaine spoons and cocaine vials;30(vii) chamber smoking pipes;31(viii) carburetor smoking pipes;32(ix) electric smoking pipes;33(x) air-driven smoking pipes;34(xi) chillums;35(xii) bongs;36(xiii) ice pipes or chillers;37(xiv) any smoking pipe manufactured to disguise its intended 38purpose;39(xv) wired cigarette papers; or40(xvi) cocaine freebase kits.41(3) "Drug paraphernalia" does not include:42(A) Any products, chemicals or materials described in K.S.A. 21-435709(a), and amendments thereto; or1(B) any materials used or intended for use to test a substance for the 2presence of fentanyl, a fentanyl analog, ketamine or gamma 3hydroxybutyric acid.4(g) "Fentanyl-related controlled substance" means any substance 5designated in K.S.A. 65-4105(b)(1), (b)(2), (b)(4), (b)(10), (b)(11), (b)6(12), (b)(15), (b)(16), (b)(17), (b)(20), (b)(21), (b)(24), (b)(26), (b)(27), (b)7(28), (b)(35), (b)(42), (b)(43), (b)(44), (b)(45), (b)(48), (b)(50), (b)(54), (b)8(55), (b)(56), (b)(57), (b)(58), (b)(59), (b)(68), (b)(70), (b)(71), (b)(72), (b)9(73), (b)(74), (b)(75), (b)(76), (b)(77), (b)(78), (b)(79), (b)(80), (b)(81), (b)10(82), (b)(83), (b)(84), (b)(85), (b)(91), (b)(97), (b)(98), (b)(99), (b)(103), 11(b)(104), (g)(1) or (g)(2) or 65-4107(c)(1), (c)(6), (c)(9), (c)(26), (c)(28), 12(c)(30), (f)(3)(A) or (f)(3)(B), and amendments thereto, or any analog 13thereof.14(h) "Immediate precursor" means a substance that the state board of 15pharmacy has found to be and by rules and regulations designates as being 16the principal compound commonly used or produced primarily for use and 17that is an immediate chemical intermediary used or likely to be used in the 18manufacture of a controlled substance, the control of which is necessary to 19prevent, curtail or limit manufacture.20(i) "Isomer" means all enantiomers and diastereomers.21(j) "Manufacture" means the production, preparation, propagation, 22compounding, conversion or processing of or placing into pill or capsule 23form a controlled substance either directly or indirectly or by extraction 24from substances of natural origin or independently by means of chemical 25synthesis or by a combination of extraction and chemical synthesis. 26"Manufacture" does not include:27(1) The preparation or compounding of a controlled substance by an 28individual for the individual's own lawful use or the preparation, 29compounding, packaging or labeling of a controlled substance:30(A) By a practitioner or the practitioner's agent pursuant to a lawful 31order of a practitioner as an incident to the practitioner's administering or 32dispensing of a controlled substance in the course of the practitioner's 33professional practice; or34(B) by a practitioner or by the practitioner's authorized agent under 35such practitioner's supervision for the purpose of or as an incident to 36research, teaching or chemical analysis or by a pharmacist or medical care 37facility as an incident to dispensing of a controlled substance; or38(2) the addition of diluents or adulterants, including, but not limited 39to, quinine hydrochloride, mannitol, mannite, dextrose or lactose that are 40intended for use in cutting a controlled substance.41(k) "Marijuana" means all parts of all varieties of the plant Cannabis 42whether growing or not, the seeds thereof, the resin extracted from any 43part of the plant and every compound, manufacture, salt, derivative, 1mixture or preparation of the plant, its seeds or resin. "Marijuana" does not 2include:3(1) The mature stalks of the plant, fiber produced from the stalks, oil 4or cake made from the seeds of the plant, any other compound, 5manufacture, salt, derivative, mixture or preparation of the mature stalks, 6except the resin extracted therefrom, fiber, oil or cake or the sterilized seed 7of the plant that is incapable of germination;8(2) any substance listed in schedules II through V of the uniform 9controlled substances act;10(3) drug products approved by the United States food and drug 11administration as of the effective date of this act;12(4) cannabidiol (other trade name: 2-[(3-methyl-6-(1-methylethenyl)-132-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol); or14(5) industrial hemp as defined in K.S.A. 2-3901, and amendments 15thereto, when cultivated, produced, possessed or used for activities 16authorized by the commercial industrial hemp act.17(l) "Minor" means a person under 18 years of age.18(m) "Narcotic drug" means any of the following whether produced 19directly or indirectly by extraction from substances of vegetable origin or 20independently by means of chemical synthesis or by a combination of 21extraction and chemical synthesis:22(1) Opium and opiate and any salt, compound, derivative or 23preparation of opium or opiate;24(2) any salt, compound, isomer, derivative or preparation thereof that 25is chemically equivalent or identical with any of the substances referred to 26in paragraph (1) but not including the isoquinoline alkaloids of opium;27(3) opium poppy and poppy straw;28(4) coca leaves and any salt, compound, derivative or preparation of 29coca leaves and any salt, compound, isomer, derivative or preparation 30thereof that is chemically equivalent or identical with any of these 31substances, but not including decocainized coca leaves or extractions of 32coca leaves that do not contain cocaine or ecgonine.33(n) "Opiate" means any substance having an addiction-forming or 34addiction-sustaining liability similar to morphine or being capable of 35conversion into a drug having addiction-forming or addiction-sustaining 36liability. "Opiate" does not include, unless specifically designated as 37controlled under K.S.A. 65-4102, and amendments thereto, the 38dextrorotatory isomer of 3-methoxy-n-methylmorphinan and its salts 39(dextromethorphan). "Opiate" does include its racemic and levorotatory 40forms.41(o) "Opium poppy" means the plant of the species Papaver 42somniferum l. except its seeds.43(p) "Person" means an individual, corporation, government or 1governmental subdivision or agency, business trust, estate, trust, 2partnership, association or any other legal entity.3(q) "Poppy straw" means all parts, except the seeds, of the opium 4poppy, after mowing.5(r) "School property" means property upon which is located a 6structure used by a unified school district or an accredited nonpublic 7school for student instruction or attendance or extracurricular activities of 8pupils enrolled in kindergarten or any of the grades one through 12. This 9definition shall not be construed as requiring that school be in session or 10that classes are actually being held at the time of the offense or that 11children must be present within the structure or on the property during the 12time of any alleged criminal act. If the structure or property meets the 13above definition, the actual use of that structure or property at the time 14alleged shall not be a defense to the crime charged or the sentence 15imposed.16(s) "Simulated controlled substance" means any product that 17identifies itself by a common name or slang term associated with a 18controlled substance and that indicates on its label or accompanying 19promotional material that the product simulates the effect of a controlled 20substance.21Sec. 5. K.S.A. 2024 Supp. 65-4101 is hereby amended to read as 22follows: 65-4101. As used in this act:23(a) "Administer" means the direct application of a controlled 24substance, whether by injection, inhalation, ingestion or any other means, 25to the body of a patient or research subject by:26(1) A practitioner or pursuant to the lawful direction of a practitioner; 27or28(2) the patient or research subject at the direction and in the presence 29of the practitioner.30(b) "Agent" means an authorized person who acts on behalf of or at 31the direction of a manufacturer, distributor or dispenser. "Agent" does not 32include a common carrier, public warehouseman or employee of the carrier 33or warehouseman.34(c) "Application service provider" means an entity that sells 35electronic prescription or pharmacy prescription applications as a hosted 36service where the entity controls access to the application and maintains 37the software and records on its server.38(d) "Board" means the state board of pharmacy.39(e) "Bureau" means the bureau of narcotics and dangerous drugs, 40United States department of justice, or its successor agency.41(f) "Controlled substance" means any drug, substance or immediate 42precursor included in any of the schedules designated in K.S.A. 65-4105, 4365-4107, 65-4109, 65-4111 and 65-4113, and amendments thereto.1(g) (1) "Controlled substance analog" means a substance that is 2intended for human consumption, and at least one of the following:3(A) The chemical structure of the substance is substantially similar to 4the chemical structure of a controlled substance listed in or added to the 5schedules designated in K.S.A. 65-4105 or 65-4107, and amendments 6thereto;7(B) the substance has a stimulant, depressant or hallucinogenic effect 8on the central nervous system substantially similar to the stimulant, 9depressant or hallucinogenic effect on the central nervous system of a 10controlled substance included in the schedules designated in K.S.A. 65-114105 or 65-4107, and amendments thereto; or12(C) with respect to a particular individual, such individual represents 13or intends the substance to have a stimulant, depressant or hallucinogenic 14effect on the central nervous system substantially similar to the stimulant, 15depressant or hallucinogenic effect on the central nervous system of a 16controlled substance included in the schedules designated in K.S.A. 65-174105 or 65-4107, and amendments thereto.18(2) "Controlled substance analog" does not include:19(A) A controlled substance;20(B) a substance for which there is an approved new drug application; 21or22(C) a substance with respect to which an exemption is in effect for 23investigational use by a particular person under section 505 of the federal 24food, drug and cosmetic act, 21 U.S.C. § 355, to the extent conduct with 25respect to the substance is permitted by the exemption.26(h) "Counterfeit substance" means a controlled substance that, or the 27container or labeling of which, without authorization bears the trademark, 28trade name or other identifying mark, imprint, number or device or any 29likeness thereof of a manufacturer, distributor or dispenser other than the 30person who in fact manufactured, distributed or dispensed the substance.31(i) "Cultivate" means the planting or promotion of growth of five or 32more plants that contain or can produce controlled substances.33(j) "DEA" means the U.S. department of justice, drug enforcement 34administration.35(k) "Deliver" or "delivery" means the actual, constructive or 36attempted transfer from one person to another of a controlled substance, 37whether or not there is an agency relationship.38(l) "Dispense" means to deliver a controlled substance to an ultimate 39user or research subject by or pursuant to the lawful order of a practitioner, 40including the packaging, labeling or compounding necessary to prepare the 41substance for that delivery, or pursuant to the prescription of a mid-level 42practitioner.43(m) "Dispenser" means a practitioner or pharmacist who dispenses, or 1a physician assistant who has authority to dispense prescription-only drugs 2in accordance with K.S.A. 65-28a08(b), and amendments thereto.3(n) "Distribute" means to deliver other than by administering or 4dispensing a controlled substance.5(o) "Distributor" means a person who distributes.6(p) (1) "Drug" means substances:7(A) Recognized as drugs in the official United States pharmacopeia, 8official homeopathic pharmacopoeia of the United States or official 9national formulary or any supplement to any of them;10(B) intended for use in the diagnosis, cure, mitigation, treatment or 11prevention of disease in human or animals;12(C) other than food intended to affect the structure or any function of 13the body of human or animals; and14(D) intended for use as a component of any article specified in 15subparagraph (A), (B) or (C).16(2) "Drug" does not include devices or their components, parts or 17accessories.18(q) "Immediate precursor" means a substance that the board has 19found to be and by rule and regulation designates as being the principal 20compound commonly used or produced primarily for use and that is an 21immediate chemical intermediary used or likely to be used in the 22manufacture of a controlled substance, the control of which is necessary to 23prevent, curtail or limit manufacture.24(r) "Electronic prescription" means an electronically prepared 25prescription that is authorized and transmitted from the prescriber to the 26pharmacy by means of electronic transmission.27(s) "Electronic prescription application" means software that is used 28to create electronic prescriptions and that is intended to be installed on the 29prescriber's computers and servers where access and records are controlled 30by the prescriber.31(t) "Electronic signature" means a confidential personalized digital 32key, code, number or other method for secure electronic data transmissions 33that identifies a particular person as the source of the message, 34authenticates the signatory of the message and indicates the person's 35approval of the information contained in the transmission.36(u) "Electronic transmission" means the transmission of an electronic 37prescription, formatted as an electronic data file, from a prescriber's 38electronic prescription application to a pharmacy's computer, where the 39data file is imported into the pharmacy prescription application.40(v) "Electronically prepared prescription" means a prescription that is 41generated using an electronic prescription application.42(w) "Facsimile transmission" or "fax transmission" means the 43transmission of a digital image of a prescription from the prescriber or the 1prescriber's agent to the pharmacy. "Facsimile transmission" includes, but 2is not limited to, transmission of a written prescription between the 3prescriber's fax machine and the pharmacy's fax machine; transmission of 4an electronically prepared prescription from the prescriber's electronic 5prescription application to the pharmacy's fax machine, computer or 6printer; or transmission of an electronically prepared prescription from the 7prescriber's fax machine to the pharmacy's fax machine, computer or 8printer.9(x) "Intermediary" means any technology system that receives and 10transmits an electronic prescription between the prescriber and the 11pharmacy.12(y) "Isomer" means all enantiomers and diastereomers.13(z) "Manufacture" means the production, preparation, propagation, 14compounding, conversion or processing of a controlled substance either 15directly or indirectly or by extraction from substances of natural origin or 16independently by means of chemical synthesis or by a combination of 17extraction and chemical synthesis and includes any packaging or 18repackaging of the substance or labeling or relabeling of its container, 19except that this term does not include the preparation or compounding of a 20controlled substance by an individual for the individual's own lawful use 21or the preparation, compounding, packaging or labeling of a controlled 22substance:23(1) By a practitioner or the practitioner's agent pursuant to a lawful 24order of a practitioner as an incident to the practitioner's administering or 25dispensing of a controlled substance in the course of the practitioner's 26professional practice; or27(2) by a practitioner or by the practitioner's authorized agent under 28such practitioner's supervision for the purpose of or as an incident to 29research, teaching or chemical analysis or by a pharmacist or medical care 30facility as an incident to dispensing of a controlled substance.31(aa) "Marijuana" means all parts of all varieties of the plant Cannabis 32whether growing or not, the seeds thereof, the resin extracted from any 33part of the plant and every compound, manufacture, salt, derivative, 34mixture or preparation of the plant, its seeds or resin. It does not include:35(1) The mature stalks of the plant, fiber produced from the stalks, oil 36or cake made from the seeds of the plant, any other compound, 37manufacture, salt, derivative, mixture or preparation of the mature stalks, 38except the resin extracted therefrom, fiber, oil or cake or the sterilized seed 39of the plant that is incapable of germination;40(2) any substance listed in schedules II through V of the uniform 41controlled substances act;42(3) drug products approved by the United States food and drug 43administration as of the effective date of this act;1(4) cannabidiol (other trade name: 2-[(3-methyl-6-(1-methylethenyl)-22-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol); or3(5) industrial hemp as defined in K.S.A. 2-3901, and amendments 4thereto, when cultivated, produced, possessed or used for activities 5authorized by the commercial industrial hemp act.6(bb) "Medical care facility" shall have the meaning ascribed to that 7term in K.S.A. 65-425, and amendments thereto.8(cc) "Mid-level practitioner" means a certified nurse-midwife 9engaging in the independent practice of midwifery under the independent 10practice of midwifery act, an advanced practice registered nurse issued a 11license pursuant to K.S.A. 65-1131, and amendments thereto, who has 12authority to prescribe drugs under K.S.A. 65-1130, and amendments 13thereto, or a physician assistant licensed under the physician assistant 14licensure act who has authority to prescribe drugs pursuant to a written 15agreement with a supervising physician under K.S.A. 65-28a08, and 16amendments thereto.17(dd) "Narcotic drug" means any of the following whether produced 18directly or indirectly by extraction from substances of vegetable origin or 19independently by means of chemical synthesis or by a combination of 20extraction and chemical synthesis:21(1) Opium and opiate and any salt, compound, derivative or 22preparation of opium or opiate;23(2) any salt, compound, isomer, derivative or preparation thereof that 24is chemically equivalent or identical with any of the substances referred to 25in paragraph (1) but not including the isoquinoline alkaloids of opium;26(3) opium poppy and poppy straw;27(4) coca leaves and any salt, compound, derivative or preparation of 28coca leaves, and any salt, compound, isomer, derivative or preparation 29thereof that is chemically equivalent or identical with any of these 30substances, but not including decocainized coca leaves or extractions of 31coca leaves that do not contain cocaine or ecgonine.32(ee) "Opiate" means any substance having an addiction-forming or 33addiction-sustaining liability similar to morphine or being capable of 34conversion into a drug having addiction-forming or addiction-sustaining 35liability. It does not include, unless specifically designated as controlled 36under K.S.A. 65-4102, and amendments thereto, the dextrorotatory isomer 37of 3-methoxy-n-methylmorphinan and its salts (dextromethorphan). It does 38include its racemic and levorotatory forms.39(ff) "Opium poppy" means the plant of the species Papaver 40somniferum l. except its seeds.41(gg) "Person" means an individual, corporation, government, or 42governmental subdivision or agency, business trust, estate, trust, 43partnership or association or any other legal entity.1(hh) "Pharmacist" means any natural person licensed under K.S.A. 265-1625 et seq., and amendments thereto, to practice pharmacy.3(ii) "Pharmacist intern" means: (1) A student currently enrolled in an 4accredited pharmacy program; (2) a graduate of an accredited pharmacy 5program serving such person's internship; or (3) a graduate of a pharmacy 6program located outside of the United States that is not accredited and who 7had successfully passed equivalency examinations approved by the board.8(jj) "Pharmacy prescription application" means software that is used 9to process prescription information, is installed on a pharmacy's computers 10and servers, and is controlled by the pharmacy.11(kk) "Poppy straw" means all parts, except the seeds, of the opium 12poppy, after mowing.13(ll) "Practitioner" means a person licensed to practice medicine and 14surgery, dentist, podiatrist, veterinarian, optometrist, or scientific 15investigator or other person authorized by law to use a controlled 16substance in teaching or chemical analysis or to conduct research with 17respect to a controlled substance.18(mm) "Prescriber" means a practitioner or a mid-level practitioner.19(nn) "Production" includes the manufacture, planting, cultivation, 20growing or harvesting of a controlled substance.21(oo) "Readily retrievable" means that records kept by automatic data 22processing applications or other electronic or mechanized recordkeeping 23systems can be separated out from all other records within a reasonable 24time not to exceed 48 hours of a request from the board or other authorized 25agent or that hard-copy records are kept on which certain items are 26asterisked, redlined or in some other manner visually identifiable apart 27from other items appearing on the records.28(pp) "Ultimate user" means a person who lawfully possesses a 29controlled substance for such person's own use or for the use of a member 30of such person's household or for administering to an animal owned by 31such person or by a member of such person's household.32Sec. 6. K.S.A. 2-3908 and K.S.A. 2024 Supp. 2-3901, 21-5701 and 3365-4101 are hereby repealed.34Sec. 7. This act shall take effect and be in force from and after its 35publication in the statute book. search keyboard_arrow_up keyboard_arrow_down Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 arrow_upward Top Kansas State Legislature

    300 SW 10th Ave, Topeka, KS 66612

    Ad Astra Per Aspera

    Kansas Legislative Hotline
    In-State: 1-800-432-3924
    Out-of-State: 785-296-2149

    Government

    • Legislators
    • House
    • Representatives
    • Senate
    • Senators
    • Committees

    Resources

    • Bills & Measures
    • Today
    • Live
    • Journals
    • Calendars
    • Archived Records
    • Laws
    • Search
    • RSS Feeds

    Support

    • Contact Us
    • Accessibility
    • Privacy Policy
    • Visit Us
    © 2026 Kansas State Legislature. All rights reserved. Data updated 0 minutes ago · 3:51 PM 11/14/2026

    Official text from the Kansas Legislature. Formatting has been adapted for reading on Ratifi.